Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 81

Sort by

Sort Order Select

Journal Articles

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

Blood (2023) 142 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2023-178624

Published: 2023

Journal Articles

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu

Blood (2023) 141 (7): 766–786.

https://doi.org/10.1182/blood.2022017046

Published: 2023

Includes: Supplemental data

Journal Articles

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

Jianming Wang, Chun-Yuan Chang, Xue Yang, Fan Zhou, Juan Liu, Sining Zhu, Xue-Zhong Yu, Chen Liu, Timothy E. O’Sullivan, Ping Xie, Zhaohui Feng, Wenwei Hu

Blood (2022) 140 (19): 2076–2090.

https://doi.org/10.1182/blood.2022015677

Published: 2022

Includes: Supplemental data

Journal Articles

Corticosteroid Treatment Impairs Epithelial Regeneration, Limiting Intestinal Recovery in Experimental Graft Vs Host Disease

Viktor Arnhold, Suze A Jansen, Winston Chang, Govindarajan Thangavelu, Paola Vinci, Shuichiro Takashima, Anastasiya Egorova, Jason Kuttiyara, Marliek van Hoesel, Chen Liu, Marco Calafiore, Bruce R. Blazar, Caroline Lindemans, Alan M Hanash

Blood (2021) 138 (Supplement 1): 88.

https://doi.org/10.1182/blood-2021-154500

Published: 2021

Journal Articles

Immune-Mediated Reprogramming of Intestinal Stem Cells Drives STAT1-Dependent Myc Expression and Epithelial Regeneration in GI-Gvhd

Shuichiro Takashima, Roshan Sharma, Anastasiya Egorova, Jason Kuttiyara, Takahiro Ito, Winston Chang, Suze A Jansen, Chen Liu, Caroline Lindemans, Linas Mazutis, Nicolas Robine, Alan M Hanash

Blood (2021) 138 (Supplement 1): 86.

https://doi.org/10.1182/blood-2021-152647

Published: 2021

Journal Articles

Transcriptomic landscape of circulating mononuclear phagocytes in Langerhans cell histiocytosis at the single-cell level

Blood (2021) 138 (14): 1237–1248.

https://doi.org/10.1182/blood.2020009064

Published: 2021

Includes: Supplemental data

Journal Articles

An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury

Blood (2020) 135 (26): 2388–2401.

https://doi.org/10.1182/blood.2019004116

Published: 2020

Includes: Supplemental data

Journal Articles

T-Cell Derived Interferon Gamma Directly Targets Intestinal Epithelium to Induce Stem Cell Apoptosis in GI Gvhd

Shuichiro Takashima, MD PhD, Maria L. Martin, PhD, Suze A. Jansen, Ya-Yuan Fu, PhD, Anastasiya Egorova, Chen Liu, MD PhD, Richard Kolesnick, MD, Caroline A. Lindemans, MD, Alan M. Hanash, MD PhD

Blood (2019) 134 (Supplement_1): 585.

https://doi.org/10.1182/blood-2019-130811

Published: 2019

Journal Articles

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty, Hung D. Nguyen, David Bastian, Chen Liu, Shikhar Mehrotra, Xue-Zhong Yu

Blood (2019) 133 (3): 266–279.

https://doi.org/10.1182/blood-2018-07-863233

Published: 2019

Includes: Supplemental data

Journal Articles

Nrf2 regulates CD4 + T cell–induced acute graft-versus-host disease in mice

Blood (2018) 132 (26): 2763–2774.

https://doi.org/10.1182/blood-2017-10-812941

Published: 2018

Includes: Supplemental data

Journal Articles

Donor T Cell Independent Mechanism Is Critical for Mediating Steroid Refractory Gvhd in Murine Models

Tomomi Toubai, MDPhD, Corrine Rossi, Isao Tawara, MD PhD, Chen Liu, MD PhD, Cynthia Zajac, Katherine Oravecz-Wilson, BS, MS, Dan Peltier, MD, Yaping Sun, MD PhD MS, Hideaki Fujiwara, MD, Mary Mansour Riwes, DO, Israel Henig, MD, Stephanie Kim, BS, Masahiro Suto, Kenichi Ishizawa, MD PhD, Pavan Reddy, MD

Blood (2018) 132 (Supplement 1): 4529.

https://doi.org/10.1182/blood-2018-99-114634

Published: 2018

Journal Articles

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Lung-Ji Chang, PhD, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Xun Lai, MD, Rui Huang, MD& PhD, Shih-Ting Tsao, MSc, Yu-Chen Liu, MSc, Rui Zhang, MSc, Lan Deng, MDPhD, Xuan Zhou, MD, Hongyu Zhang, PhD MD, Wenli Zhang, MD, Yuchen Li, MSc

Blood (2018) 132 (Supplement 1): 225.

https://doi.org/10.1182/blood-2018-99-114396

Published: 2018

Journal Articles

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

Yongxia Wu, Steven Schutt, Katelyn Paz, Mengmeng Zhang, Ryan P. Flynn, David Bastian, M. Hanief Sofi, Hung Nguyen, Min Dai, Chen Liu, Ying-Jun Chang, Bruce R. Blazar, Xue-Zhong Yu

Blood (2018) 131 (17): 1974–1986.

https://doi.org/10.1182/blood-2017-06-789321

Published: 2018

Includes: Supplemental data

Journal Articles

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

Lihua Yang, MDPhD, Xiaoli Ma, MDPhD, Yu-Chen Liu, MSc, Wen Zhao, MDPhD, Lihua Yu, PhD, Maoquan Qin, MDPhD, Guanghua Zhu, MDPhD, Kai Wang, MDPhD, Xiaodong Shi, MD, Zhaoxia Zhang, MD, Jingfu Wang, MD, Yuan Sun, MD, Lujia Dong, MD, Shih-Ting Tsao, MSc, Rui Zhang, MSc, Lung-Ji Chang, PhD

Blood (2017) 130 (Supplement 1): 3335.

https://doi.org/10.1182/blood.V130.Suppl_1.3335.3335

Published: 2017

Journal Articles

Nrf2 Is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease

Jennifer Tsai, MD PhD, Enrico Velardi, PhD BS, Yusuke Shono, MD PhD, Kimon Argyropoulos, MD, Odette M. Smith, BA, Amina Lazrak, BS, Chen Liu, MD PhD, George F Murphy, MD, Ya-Yuan Fu, PhD, Alan M. Hanash, Robert R. Jenq, MD, Jarrod A Dudakov, PhD, Marcel R.M. van den Brink, MD PhD

Blood (2017) 130 (Supplement 1): 205.

https://doi.org/10.1182/blood.V130.Suppl_1.205.205

Published: 2017

Journal Articles

Double CD19/CD22 Chimeric Antigen Receptor-Modified T Cells for the Treatment of Stage IV Relapsed and Refractory Follicular Lymphoma

Xun Lai, MD, Xuezhong Gu, MD, Shih-Ting Tsao, MSc, Qin Zhang, PhD, Yu-Chen Liu, MSc, Jiang Yaxian, PhD, Li Yan, MD, Jun Chun, MD, Rui Zhang, MSc, Yunyun Du, MD, Xiaoli Gao, MD, Yingyu Yang, Xiaolian Qiu, Mingjing Fang, MA, Song Wei, PhD, Lung-Ji Chang, PhD

Blood (2017) 130 (Supplement 1): 5154.

https://doi.org/10.1182/blood.V130.Suppl_1.5154.5154

Published: 2017

Journal Articles

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, PhD, Lujia Dong, MD, Yu-Chen Liu, MSc, Shih-Ting Tsao, MSc, Ya-Chen Li, PhD, Li Liu, MD, Zhiyong Gao, MD, Xiyou Tan, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, Jing-Bo Wang, Yu-Ming Ying, MD, Le-Ping Zhang, MD, Huyong Zheng, MD PhD, Kai Wang, MD PhD, Xiao-Li Zheng, MD, Heng-Xiang Wang, MD, Xun Lai, MD, Dong Li, MD

Blood (2016) 128 (22): 587.

https://doi.org/10.1182/blood.V128.22.587.587

Published: 2016

Journal Articles

Microbial Metabolite Sensor GPCR43 Controls Severity of Experimental Gvhd

Hideaki Fujiwara, MD PhD, Nathan Mathewson, PhD, Tomomi Toubai, MD PhD, Katherine Oravecz-Wilson, MS, Cynthia Zajac, BS, Julia Wu, BS, Yaping Sun, MD PhD, Chen Liu, MD PhD, Pavan R. Reddy, MD

Blood (2016) 128 (22): 1157.

https://doi.org/10.1182/blood.V128.22.1157.1157

Published: 2016

Journal Articles

Development of a Triazolyldisulfide Compound That Increases the Affinity of Hemoglobin for Oxygen and Reduces Hypoxic Sickling of Sickle Cells

Akito Nakagawa, PhD, Ferrari Michele, MD, Chen Liu, PhD, Lorenzo Berra, MD, Elizabeth S. Klings, MD, Martin K. Safo, PhD, Donald B. Bloch, MD, Osheiza Abdulmalik, DVM, MS, Warren M. Zapol, MD

Blood (2016) 128 (22): 3642.

https://doi.org/10.1182/blood.V128.22.3642.3642

Published: 2016

Journal Articles

Donor T Cells Intrinsic Responses to Damps Regulated By Siglec-G-CD24 Axis Mitigate Gvhd but Maintain GVL in Experimental BMT Model

Tomomi Toubai, MD PhD, Corinne Rossi, MD, Katherine Oravecz-Wilson, MS, Nathan Mathewson, PhD, Cynthia Zajac, BS, Chen Liu, MD PhD, Stuart Brabbs, Bailey Redman, BS, Hiroya Tamaki, MD PhD, Julia Wu, BS, Yaping Sun, MD PhD, Pang Zheng, MD PhD, Yang Liu, PhD, Pavan Reddy, MD

Blood (2015) 126 (23): 229.

https://doi.org/10.1182/blood.V126.23.229.229

Published: 2015

NARROW

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

Corticosteroid Treatment Impairs Epithelial Regeneration, Limiting Intestinal Recovery in Experimental Graft Vs Host Disease

Immune-Mediated Reprogramming of Intestinal Stem Cells Drives STAT1-Dependent Myc Expression and Epithelial Regeneration in GI-Gvhd

Transcriptomic landscape of circulating mononuclear phagocytes in Langerhans cell histiocytosis at the single-cell level

An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury

T-Cell Derived Interferon Gamma Directly Targets Intestinal Epithelium to Induce Stem Cell Apoptosis in GI Gvhd

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Nrf2 regulates CD4 + T cell–induced acute graft-versus-host disease in mice

Donor T Cell Independent Mechanism Is Critical for Mediating Steroid Refractory Gvhd in Murine Models

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

Nrf2 Is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease

Double CD19/CD22 Chimeric Antigen Receptor-Modified T Cells for the Treatment of Stage IV Relapsed and Refractory Follicular Lymphoma

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Microbial Metabolite Sensor GPCR43 Controls Severity of Experimental Gvhd

Development of a Triazolyldisulfide Compound That Increases the Affinity of Hemoglobin for Oxygen and Reduces Hypoxic Sickling of Sickle Cells

Donor T Cells Intrinsic Responses to Damps Regulated By Siglec-G-CD24 Axis Mitigate Gvhd but Maintain GVL in Experimental BMT Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only